PortfoliosLab logoPortfoliosLab logo
Moolec Science SA Warrant (MLECW)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

IPO Date
Jan 3, 2023

Highlights

Total Revenue (TTM)
$7.83M
Gross Profit (TTM)
-$639.50K
EBITDA (TTM)
-$5.21M
Year Range
$0.00 - $0.16

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Moolec Science SA Warrant

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Moolec Science SA Warrant, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Moolec Science SA Warrant (MLECW) has returned 344.83% so far this year and 203.53% over the past 12 months.


Moolec Science SA Warrant

1D
-6.18%
1M
-54.97%
YTD
344.83%
6M
138.89%
1Y
203.53%
3Y*
-38.74%
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jan 3, 2023, MLECW's average daily return is +1.32%, while the average monthly return is +13.16%. At this rate, your investment would double in approximately 0.5 years.

Historically, 49% of months were positive and 51% were negative. The best month was Feb 2026 with a return of +558.6%, while the worst month was Mar 2025 at -78.3%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 4 months.

On a daily basis, MLECW closed higher 26% of trading days. The best single day was Dec 26, 2024 with a return of +228.0%, while the worst single day was Mar 26, 2025 at -58.5%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202650.00%558.62%-54.97%344.83%
202523.23%25.24%-78.32%98.82%-26.63%31.45%14.72%-43.85%2.86%18.52%-10.16%-49.57%-77.17%
202481.36%43.86%-51.05%87.54%13.85%-16.67%30.00%-46.00%13.96%-0.25%10.03%-42.14%15.45%
2023-28.62%33.42%-43.90%-18.98%-14.41%2.70%-13.39%-6.79%-45.58%-28.49%19.52%-26.67%-89.52%

Benchmark Metrics

Moolec Science SA Warrant has an annualized alpha of 2131.49%, beta of 1.11, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since January 04, 2023.

  • This stock participated in 204.97% of S&P 500 Index downside but only -88.32% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
2,131.49%
Beta
1.11
0.00
Upside Capture
-88.32%
Downside Capture
204.97%

Return for Risk

Risk / Return Rank

MLECW ranks 75 for risk / return — better than 75% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


MLECW Risk / Return Rank: 7575
Overall Rank
MLECW Sharpe Ratio Rank: 6363
Sharpe Ratio Rank
MLECW Sortino Ratio Rank: 9595
Sortino Ratio Rank
MLECW Omega Ratio Rank: 9494
Omega Ratio Rank
MLECW Calmar Ratio Rank: 6464
Calmar Ratio Rank
MLECW Martin Ratio Rank: 5959
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Moolec Science SA Warrant (MLECW) and compare them to a chosen benchmark (S&P 500 Index).


MLECWBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.64

0.90

-0.26

Sortino ratio

Return per unit of downside risk

3.55

1.39

+2.16

Omega ratio

Gain probability vs. loss probability

1.47

1.21

+0.26

Calmar ratio

Return relative to maximum drawdown

1.06

1.40

-0.34

Martin ratio

Return relative to average drawdown

1.84

6.61

-4.77

Explore MLECW risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Moolec Science SA Warrant doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Moolec Science SA Warrant. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Moolec Science SA Warrant was 97.82%, occurring on Jan 9, 2026. The portfolio has not yet recovered.

The current Moolec Science SA Warrant drawdown is 88.27%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-97.82%Feb 28, 2023718Jan 9, 2026
-46%Jan 4, 202317Jan 27, 202320Feb 27, 202337

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Moolec Science SA Warrant over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Moolec Science SA Warrant is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items